PIPAC for Peritoneal Metastases of Colorectal Cancer

ABSTRACT: This is multicentre, open-label, single-arm phase II study that investigates the feasibility, safety, tolerability, preliminary efficacy, costs, and pharmacokinetics or repetitive electrostatic pressurised intraperitoneal aerosol chemotherapy (ePIPAC-OX) as a palliative monotherapy for patients with isolated unresectable colorectal peritoneal metastases.

DISEASE(S): Geïsoleerde Irresectabele Colorectale Peritoneale Metastasen,Carcinoma,Appendixcarcinoom,Cecal Neoplasms,Peritoneal Carcinomatosis,Neoplasms,Appendiceal Neoplasms,Peritoneal Metastases,Peritoneal Neoplasms,Isolated Unresectable Colorectal Peritoneal Metastases,Peritoneale Metastasen,Colorectal Neoplasms,Peritonitis Carcinomatosa,Colorectaal Carcinoom

PROVIDER: 2251531 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR